	The Clinical Trials Transformation Initiative (

) is a public-private partnership to identify practices that will increase the quality and efficiency of clinical trials founded by the FDA and Duke University. Recently, at the 48th Annual DIA Meeting, serveral CTTI projects were presented. These included Cynthia Hahn, Research Compliance Officer, Feinstein Institute for Medical Research, presentation, “Use of Central IRBs for Multicenter Clinical Trials” and addressed solicitation of current perceptions of barriers, development of a strategy to address identified barriers, and assessment reactions to proposed solutions to remove barriers.

	The “Site Metrics for Study Start Up” project was delivered by Adam Chasse, MHA, Vice President, RxTrials, who explained the data collection, collaboration, and processes of the project.

 slideshows and a video on the IRB project.